Cite
MLA Citation
Craig L. Slingluff et al.. “A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma.” Oncoimmunology, vol. 10, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100124341818.0x00000c